Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Armadillo repeat-containing X-linked protein 4 (ARMCX4) is a member of the armadillo repeat-containing family of proteins, sharing structural similarity with scaffolding and adaptor proteins that regulate cellular processes such as intracellular trafficking and signal transduction[1][3][5]. Although its precise functions are not fully elucidated, ARMCX4 is thought to participate in the regulation of G protein–coupled receptor trafficking, post-endocytic sorting, and possibly other signaling processes via protein-protein interactions[1][3]. Research also implicates ARMCX4 in the differentiation of spermatogonial stem cells and in pathologies such as congenital myasthenic syndrome, cancer, glycosylation disorders, male infertility, and neonatal maxillofacial deformity[3][5]. ARMCX4 is not currently recognized as a classical therapeutic target such as a receptor, enzyme, or transporter, and there are no known drugs or established clinical biomarkers directly targeting this protein[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Armadillo repeat-containing X-linked protein 4 (ARMCX4).